Recent Zofran Birth Defects Lawsuit News:

Australian Zofran Study Finds Increased Risk Of Birth Defects | 1/27/2016

The 2013 research study published in BioMed Research International concluded that Zofran increases a child's risk of being born with birth defects by 20 percent....READ MORE

GSK Files To Dismiss All Zofran MDL Lawsuits | 1/20/2016

The company is arguing that a clear evidence preemption necessitates the dismissal of the claims, while plaintiffs accuse the defendant of trying to apply a broad precedent to a handful of lawsuits....READ MORE

Diversity In Severity Of Defects Allegedly Caused By Zofran | 1/13/2016

From cleft palates to babies dying in the womb, the severity of the injuries sustained by birth defects caused by the anti-nausea drug Zofran have ranged from treatable to fatal in the cases recently filed against the medication's manufacturer GlaxoSmithKline....READ MORE

Zofran MDL Lawsuits Top 200 Total | 1/6/2016

The number of lawsuits in the Zofran birth defect multidistrict litigation has grown from 15 at the time of consolidation to more than 200 total cases....READ MORE

Questions Of Fact In Zofran MDL Lawsuits | 12/30/2015

There are a number of questions of fact that bind all the lawsuits filed against GlaxoSmithKline for the connection between their medication Zofran and an increased risk in birth defects....READ MORE

Direct Filing Allowed In Zofran MDL | 12/23/2015

The judge presiding over the Zofran MDL against GlaxoSmithKline allowed for the direct filing of Zofran lawsuits to helped streamline the litigative process for potential plaintiffs....READ MORE

Total Zofran Lawsuits Expected To Top 200 | 12/16/2015

Beginning with just 15 lawsuits initially transferred, the Zofran birth defect MDL is currently well over 150 lawsuits and growing steadily....READ MORE

Idaho Lawsuit Claims GSK Didn't Test Zofran On Humans | 12/9/2015

The lawsuit claims that only four animals studies were submitted to the FDA when GSK originally pursued approval for Zofran, and even these contained complications following pregnancy....READ MORE

Doctors Still Able To Prescribe Zofran For Morning Sickness | 12/2/2015

Even with hundreds of lawsuits pending around the country, Zofran's approved use for anti-nausea allows doctors to prescribe the drug off-label for morning sickness if they so choose....READ MORE

Updates for Zofran MDL Heading Into Month Two Of Consolidation | 11/25/2015

The number of lawsuits against GlaxoSmithKline continues to grow and be added to the MDL , while the plaintiffs have selected three lawyers to represent them in the federal proceedings....READ MORE

Zofran Birth Defect Lawsuits Top 100 Nationwide | 11/18/2015

More than 100 lawsuits alleging that the GlaxoSmithKline anti-nausea medication Zofran is linked to an increased risk of birth defects have been filed around the country to date....READ MORE

New Zofran Lawsuit Filed In Idaho | 11/11/2015

A mother whose child was born with congenital band syndrome and club foot in 2007 has filed a lawsuit against GlaxoSmithKline for the side effects in their anti-nausea medication Zofran that allegedly caused the defects....READ MORE

First Zofran Status Conference Set For November 17 | 11/4/2015

The first status conference in the recently transferred Zofran birth defect MDL is scheduled to take place on Tuesday, November 17....READ MORE

New Alabama Zofran Lawsuit Filed | 10/28/2015

An Alabama family has filed a lawsuit GlaxoSmithKline, claiming the pharmaceutical company pushed for Zofran to be prescribed off-label to a pregnant mother and contributed to the child's development of a serious heart defect upon birth....READ MORE

Four Separate Plaintiffs File Zofran Claim Together | 10/21/2015

Four plaintiffs, all from different states, have decided to file a Zofran birth defect lawsuit against GlaxoSmithKline together, claiming the medication contributed to their children's birth defects....READ MORE

Zofran Lawsuits Consolidated by JPML | 10/14/2015

12 Zofran lawsuits, as well as 42 tag-along actions, were transferred to the District of Massachusetts federal court by the Judicial Panel on Multidistrict Litigation on October 13....READ MORE

Oregon Family Files New Zofran Lawsuit | 10/7/2015

The parents of a child that was born with a heart defect have filed a lawsuit against GlaxoSmithKline claiming that the company’s reckless off-label marketing of their anti-nausea drug Zofran contributed to the child’s development of a serious birth defect....READ MORE

Toronto Star Zofran Report Significant In Plaintiffs' Arguments | 9/30/2015

A 2014 investigative report conducted by the Toronto Star identified at least 20 women that had suffered birth defects allegedly connected to physician's prescribing the women Zofran to help treat morning sickness symptoms....READ MORE

Lawsuits Grow Nationwide As MDL Decision Nears | 9/16/2015

Zofran birth defect lawsuits continue to be filed across the country as GSK prepares to argue for consolidation before the JPML on October 1....READ MORE

Two New Zofran Lawsuits Claim Birth Defects From 1990's | 9/9/2015

Two plaintiffs from Ohio have filed lawsuits against GlaxoSmithKline claiming that the pharmaceutical manufacturer's Zofran medication caused their children to suffer birth defects in the 1900's....READ MORE

New Zofran Lawsuit Claims GSK Drug Led To Child's Single Kidney | 9/2/2015

A lawsuit filed July 27 in North Dakota claims that off-label marketing led to a doctor prescribing Zofran to a pregnant mother, allegedly contributing to her son being born with only one kidney....READ MORE

JPML Will Hear GSK Motion To Transfer In October | 8/26/2015

The Judicial Panel on MultiDistrict Litigation will hear arguments concerning the possible centralizing of the Zofran birth defect lawsuits into multidistrict litigation during its October Hearing Session....READ MORE

Zofran Lawsuits Top 30 Nationwide As GSK Spokesperson Denies Liability | 8/19/2015

The number of lawsuits against GSK continues to climb steadily, while a spokesperson for the company denies the actions taken by the defendant render them liable for claims filed by the plaintiffs....READ MORE

Two New Zofran Lawsuits Filed In Illinois And North Dakota | 8/12/2015

The new claims filed against GlaxoSmithKline bring similar allegations of birth defects caused by the company’s Zofran medication that resulted the defendant filing a motion to transfer the lawsuits into multidistrict litigation in July....READ MORE

FDA Plans Public Meeting Regarding Off-Label Medication | 8/5/2015

A public meeting was scheduled by the FDA to discuss a push by pharmaceutical companies to streamline the release of new drugs, bypassing some measures protecting against the kind of off-label marketing that contributed to Zofran birth defect problems....READ MORE

New Report Released Intended To Advise Potential Zofran Plaintiffs. | 7/29/2015

The package released by The Medical Compensation Help Team reportedly takes potential Zofran birth defect plaintiffs through a series of tips to assist them in their pursuit of damages from GSK....READ MORE

New Zofran Lawsuits Filed In Alabama and Louisiana | 7/22/2015

As news of the link between Zofran and birth defects builds, more lawsuits around the country are popping up claiming that GlaxoSmithKline contributed to birth defects in the children of mothers prescribed Zofran while pregnant....READ MORE

Zofran Lawsuits Expected To Rise After MDL Request | 7/15/2015

The number of Zofran birth defect lawsuits, currently at 12, is expected to rise in the coming months after defendant GlaxoSmithKline filed a motion to transfer the lawsuits before the Eastern District of Pennsylvania U.S. District Court on July 7....READ MORE

GSK Files Motion To Transfer 12 Zofran Lawsuits Into MDL | 7/8/2015

A motion to transfer 12 Zofran birth defect lawsuits to the federal court in Eastern District of Pennsylvania was filed July 7 by GlaxoSmithKline....READ MORE

Research Linking Zofran and Birth Defects Prevalent Throughout US | 7/1/2015

Multiple studies and reports investigating the link between Zofran and birth defects in children whose mothers took the medication while pregnant have found significant evidence supporting an increased risk in cleft palates, heart defects and more serious conditions when a child is exposed to the drug in utero....READ MORE

Families Around U.S. Filing Claims On Behalf Of Children Affected By Zofran | 6/22/2015

The number of claims against pharmaceutical manufacturer GlaxoSmithKline has recently reached into double digits as more families are discovering that the exposure to Zofran in the womb has been linked to birth defects by a number of studies....READ MORE

New Zofran Lawsuit In Ohio Claims Drug Caused Death of Daughter | 6/14/2015

The latest Zofran birth defects lawsuit filed against GlaxoSmithKline claims the death of a three-day-old baby due to heart complications was connected to the company's anti-nausea drug never approved by the FDA for morning-sickness use....READ MORE

Plaintiffs Continue To File New Zofran Lawsuits | 6/10/2015

Allegations alleging a connection between the medication Zofran and birth defects found in the children of pregnant mothers who took the drug are the base for new lawsuits against pharmaceutical manufacturer GlaxoSmithKline....READ MORE

New Zofran Lawsuit Filed in Alabama | 4/9/2015

A woman who alleges her son suffered serious birth defects as a result of prenatal exposure to Zofran has filed a lawsuit against GlaxoSmithKline....READ MORE

No-Cost, No-Obligation Zofran Birth Defect Lawsuit Case Review If You or a Loved One Has Had a Baby with Birth Defects

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others, and other law firms throughout the nation often seek its experience and expertise on complex litigation.